KNSA vs NUE · P/E 53, rev $677.6M vs P/E 25, rev $19.89B
Kiniksa Pharmaceuticals Ltd (KNSA) versus Nucor Corp (NUE) — a side-by-side from cached financials, not a winner call.
Kiniksa Pharmaceuticals Ltd (KNSA) is a drug manufacturers - specialty & generic company listed on US.
Nucor Corp (NUE) is a steel company listed on NYSE.
Latest reported KNSA revenue for 2025-12-31 was $677.6M. Net income was $59.0M. Revenue was up 60.1% from 2024-12-31 to 2025-12-31. KNSA currently screens at market cap $3.73B and trailing P/E 53.2.
Latest reported NUE revenue for 2026-07-04 was $19.89B. Net income was $1.90B. NUE currently screens at market cap $57.53B and trailing P/E 25.1.
KNSA currently screens at market cap $3.73B and trailing P/E 53.2. NUE currently screens at market cap $57.53B and trailing P/E 25.1.
Not investment advice. Open the KNSA and NUE stock pages for the full models.
Not investment advice.